Physician profile
Steven Wang
NPI 1023244654
$1,929.30
in general payments reported to CMS, 2019-2025
9 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what 84% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $87.93 · 2021: $23.32 · 2022: $110 · 2023: $35.01 · 2024: $99.38 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $942 · Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $941.70 |
| Food and Beverage | $455.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $955.66 | 2024-2025 | Ips, Supplemental Model, Half, 00132, Qty: 001 Ea |
| Depuy Synthes Sales INC. | $456.51 | 2019-2025 | Na, Trumatch, Matrixorthognathic |
| Geistlich Pharma, North America, INC. | $144.02 | 2019-2020 | |
| Nobel Biocare USA | $137.06 | 2019-2020 | |
| Biohorizons Implant Systems INC. | $85.36 | 2025 | Biohorizons Dental Implants |
| Bioventus LLC | $63.67 | 2021-2024 | Bonescalpel & Sonicone (O.R.) |
| Medical Device Business Services, INC. | $52.01 | 2025 | Trumatch, Na, Matrixorthognathic |
| Dentsply Sirona INC | $20.85 | 2023 | Astra Tech Implant System |
| Pfizer INC. | $14.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.